gatsuciclib   Click here for help

GtoPdb Ligand ID: 13385

Synonyms: AZD-8421 | AZD8421
Compound class: Synthetic organic
Comment: AZD8421 is an orally bioactive, selective inhibitor of the Ser/Thr kinase cyclin-dependent kinase 2 (CDK2) [1]. CDK2 inhibition is proposed as a route to combat CDK4/6 inhibitor resistance mechanisms that evolve in breast cancer. The chemical structure was matched to that for the INN gatsuciclib, as disclosed in WHO INN Proposed List 135 (July 2026).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 11
Hydrogen bond donors 4
Rotatable bonds 10
Topological polar surface area 142.4
Molecular weight 440.57
XLogP -0.02
No. Lipinski's rules broken 1

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC[C@@H]([C@@H](C)O)NC1=NC2=C(C(=N1)N[C@H]3CCN(C3)S(=O)(=O)NCC)N=CN2CC
Isomeric SMILES CC[C@@H]([C@@H](C)O)NC1=NC(=C2C(=N1)N(C=N2)CC)N[C@H]3CCN(C3)S(=O)(=O)NCC
InChI InChI=1S/C18H32N8O3S/c1-5-14(12(4)27)22-18-23-16(15-17(24-18)25(7-3)11-19-15)21-13-8-9-26(10-13)30(28,29)20-6-2/h11-14,20,27H,5-10H2,1-4H3,(H2,21,22,23,24)/t12-,13+,14+/m1/s1
InChI Key ROGNUCVYDNPNJI-RDBSUJKOSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. Denz CR, Grondine M, Fan J, Hsu JHR, Jackson A, Robinson J, Guo G, Li W, Wang Y, San Martin M et al.. (2024)
Abstract 5730: Targeting the cell cycle with AZD8421, a potent and highly selective CDK2 inhibitor.
Cancer Research, 84 (6_Supplement). DOI: 10.1158/1538-7445.AM2024-5730